Are SGLT2 Inhibitors New Hypertension Drugs?

Kazuomi Kario; Keith C. Ferdinand; Wanpen Vongpatanasin

doi:10.1161/CIRCULATIONAHA.121.053709

Are SGLT2 Inhibitors New Hypertension Drugs?

Kazuomi Kario, Keith C. Ferdinand, Wanpen Vongpatanasin

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1750-1753
Number of pages	4
Journal	Circulation
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.121.053709
State	Accepted/In press - 2021

Keywords

drug therapy
Editorials
hypertension
sodium-glucose transporter 2 inhibitors

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.121.053709

Cite this

@article{878a8dc6ab9c4f53ba80301d2bf729b5,

title = "Are SGLT2 Inhibitors New Hypertension Drugs?",

keywords = "drug therapy, Editorials, hypertension, sodium-glucose transporter 2 inhibitors",

author = "Kazuomi Kario and Ferdinand, {Keith C.} and Wanpen Vongpatanasin",

year = "2021",

doi = "10.1161/CIRCULATIONAHA.121.053709",

language = "English (US)",

pages = "1750--1753",

journal = "Circulation",